Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs
Darius Tahir·
·1 min read
·
0 reactions
·
0 comments
·
13 views
New ethics disclosures show the president invested in Eli Lilly and a company that manufactures injectable devices as his health agencies implemented policies that benefited them.
Original article
KFF Health News · Darius Tahir
Opening excerpt (first ~120 words) tap to expand
Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up. For all of President Donald Trump’s showmanship, the share of Americans his policies will likely help remains slim, even if some patients do come out ahead. By Elisabeth Rosenthal and Arthur Allen May 7, 2026
Excerpt limited to ~120 words for fair-use compliance. The full article is at KFF Health News.
Anonymous · no account needed
Discussion
0 commentsMore from KFF Health News
At a Tennessee Hospital, a Nurse Stole Fentanyl and AI Missed It, State Records Say
KFF Health News·22
Michigan Found a Way To Reduce School Vaccine Waivers. Until It Backfired.
KFF Health News·22
Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
KFF Health News·21
Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
KFF Health News·19
Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
KFF Health News·21
Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
KFF Health News·22